Prevalence of serotype 19A Streptococcus pneumoniae among isolates from US children in 2005-2006 and activity of faropenem

被引：24

作者：

Critchley, Ian A. ^{[1
]}

Jacobs, Michael R. ^{[2
,3
]}

Brown, Steven D. ^{[4
]}

Traczewski, Maria M. ^{[4
]}

Tillotson, Glenn S. ^{[5
]}

Janjic, Nebojsa ^{[1
]}

机构：

[1] Replidyne Inc, Louisville, CO 80027 USA

[2] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA

[3] Case Western Reserve Univ Hosp, Case Med Ctr, Cleveland, OH 44106 USA

[4] Inst Clin Microbiol, Wilsonville, OR 97070 USA

[5] Replidyne Inc, Milford, CT 06460 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2008年 / 52卷 / 07期

关键词：

D O I：

10.1128/AAC.00310-08

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Of 393 isolates of Streptococcus pneumoniae from U.S. children collected in 2005-2006, nonvaccine serotypes accounted for 89.1%, with serotype 19A the most prevalent, representing 30.5% of all isolates. The MIC,, of faropenem against serotype 19A isolates was 1 mu g/ml, compared to >= 8 mu g/ml against amoxicillin/clavulanate, cefdinir, cefuroxime axetil, and azithromycin.

引用

页码：2639 / 2643

页数：5

共 35 条

[1]

Abramson JS, 2000, PEDIATRICS, V106, P362

[2] Serotype prevalence of occult pneumococcal bacteremia [J].